Importance of Therapeutic Drug Monitoring to Detect Drug Interaction between Pazopanib and Warfarin: A Case Report

• Päätekijät: Shinya Takasaki (Tekijä), Hisanobu Adachi (Tekijä), Yoshihide Kawasaki (Tekijä), Masafumi Kikuchi (Tekijä), Akihiro Ito (Tekijä), Nariyasu Mano (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2020-05-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Pazopanib is an orally available multi-tyrosine kinase inhibitor and has been used to treat renal cell carcinoma (RCC). Here, we report the case of a patient with RCC with an increased prothrombin time-international normalized ratio (PT-INR) due to pazopanib therapy. In addition, we have reported th...